Translation and validation of the Chinese version of the stroke knowledge test for the hypertension patient.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 10 2023
14 10 2023
Historique:
received:
25
03
2023
accepted:
11
10
2023
medline:
23
10
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
The measurement of hypertensive patients' stroke knowledge is an important stroke prevention indicator of health care service quality. The aim of this study was to develop a Chinese version of the Stroke Knowledge Test and examine its psychometric properties, reliability, and validity for hypertensive patients. A sample of 200 hypertensive patients completed the Chinese version of the Stroke Knowledge Test, and 30 of the participants were retested after 2 weeks. The final Chinese version of the Stroke Knowledge Test included 20 items with acceptable content validity (I-CVI = 0.88 ~ 1.00, S-CVI/Ave = 0.97). These items showed satisfactory internal reliability consistency (Kuder Richardson-20 = 0.62) and test-retest reliability was 0.77. The 40% of the difficulty index was in the acceptable range, and 25% was in the difficult range, as well as the 90% items overall values for discrimination were ranged from 0.2 to > 0.4. Known-group validity testing was performed based on the education level, and the result exhibited significant difference (F = 21.21, p < 0.001). The Chinese version of the Stroke Knowledge Test demonstrated acceptable psychometric properties, thus providing a new tool for the future care of hypertensive patients in Taiwan. It also could be as a reference for healthcare providers to educate hypertensive patients on stroke prevention.
Identifiants
pubmed: 37838764
doi: 10.1038/s41598-023-44682-7
pii: 10.1038/s41598-023-44682-7
pmc: PMC10576787
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
17446Informations de copyright
© 2023. Springer Nature Limited.
Références
Risk Manag Healthc Policy. 2021 Apr 22;14:1681-1688
pubmed: 33911905
Eur Cardiol. 2019 Jul 11;14(2):111-115
pubmed: 31360232
Lancet Public Health. 2022 Jan;7(1):e74-e85
pubmed: 34756176
Clin Med Insights Cardiol. 2014 Nov 10;8(Suppl 2):9-13
pubmed: 25452703
J Arrhythm. 2016 Apr;32(2):112-8
pubmed: 27092192
Top Stroke Rehabil. 2004 Summer;11(3):19-28
pubmed: 15480951
Stroke. 2013 Dec;44(12):3293-7
pubmed: 24065711
Afr J Emerg Med. 2021 Mar;11(1):10-14
pubmed: 33318912
J Cardiovasc Nurs. 2017 May/Jun;32(3):271-280
pubmed: 27203274
Acta Cardiol Sin. 2022 May;38(3):225-325
pubmed: 35673334
Ann Glob Health. 2020 Jul 23;86(1):83
pubmed: 32742941
Res Nurs Health. 2006 Oct;29(5):489-97
pubmed: 16977646
Nurs Res. 1986 Nov-Dec;35(6):382-5
pubmed: 3640358
Nurs Res. 2001 Sep-Oct;50(5):300-4
pubmed: 11570715
J Int Med Res. 2019 Sep;47(9):4230-4241
pubmed: 31307252
Neurol Res Int. 2019 Jun 23;2019:8570428
pubmed: 31341680
Int J Rheum Dis. 2020 Jul;23(7):918-927
pubmed: 32525287
J Nurs Scholarsh. 2007;39(2):155-64
pubmed: 17535316
Res Nurs Health. 2007 Aug;30(4):459-67
pubmed: 17654487
Patient Educ Couns. 1996 Aug;28(3):265-76
pubmed: 8852102
Stroke. 2005 May;36(5):1035-9
pubmed: 15817898
Disabil Rehabil. 2021 Feb;43(3):345-353
pubmed: 31169419
Brain Sci. 2020 Dec 18;10(12):
pubmed: 33353075
Int J Stroke. 2020 Oct;15(8):819-838
pubmed: 32146867
Cardiovasc Diabetol. 2019 Jul 9;18(1):88
pubmed: 31288813
J Clin Med. 2020 Aug 07;9(8):
pubmed: 32784554
Educ Psychol Meas. 1947 Summer;7(2):191-205
pubmed: 20256558